ISSN: 0006-3223

Journal Home

Journal Guideline

Biological Psychiatry Q1 Unclaimed

Elsevier Inc. United States

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Biological Psychiatry is a journal indexed in SJR in Biological Psychiatry with an H index of 356. It has a price of 2040 €. It has an SJR impact factor of 3,786 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,786.

Biological Psychiatry focuses its scope in these topics and keywords: stress, functional, magnetic, schizophrenia, disorder, imaging, expression, association, stimulation, sleep, ...

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy:

Type of publications:

Publication frecuency: -

Categories: Biological Psychiatry (Q1)

Price

2040 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

3,786

SJR Impact factor

356

H Index

314

Total Docs (Last Year)

846

Total Docs (3 years)

16137

Total Refs

5371

Total Cites (3 years)

526

Citable Docs (3 years)

6.1

Cites/Doc (2 years)

51.39

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

The Lancet Psychiatry Q1
Dialogues in Clinical Neuroscience Q1
Translational Psychiatry Q1
Psychiatry Research Q1
Biological Psychiatry: Cognitive Neuroscience and Neuroimaging Q1

Compare this journals

Aims and Scope

Best articles by citations

248. Protein kinase A in the postmortem brain of suicide victims

357. Altered relationships in RCMRGLU associativity in bipolar and unipolar illness

122. Effects of caffeine on sensorimotor gating of the startle reflex in normal control subjects

407. Altered prefrontal-thalamic neuronal integrity in bipolar I disorder

160. Nicotine replacement and smoking suppression in schizophrenia

76. Reaction time slowing in schizophrenia: domain-specific features

361. 5-HTTLPR and central 5-HTT availability measured with [123I]-beta-CIT SPECT

365. Emotion-inducing stimuli processing in alexithymia: an fMRI study

369. Psychotropic drug naive and currently treated patients with Tourette syndrome: a [123I]-beta-CIT SPECT-study

Circulating Lymphocyte Phenotypic Surface Markers in Anxiety Disorder Patients and Normal Volunteers

164. Attenuated frontal activation during mental rotation in schizophrenia

126. Working memory impairment in schizophrenia patients and their first-degree relatives

SHOW MORE ARTICLES

374. Deep brain stimulation: a new treatment for Parkinson's disease with mood altering potential

Attentional disorders in schizophrenia: Influence of neuroleptic treatment and correlation between cognitive performances and clinical features

377. Involvement of the vagus nerves and associated CNS pathways in psychiatric disorders

168. Volumetric MRI in male violent offenders with schizophrenia and psychopathic disorder

252. Platelet activation of depressed patients in comparison to patients with aortic atherosclerosis

Sleep electroencephalographic abnormalities in adolescent depressives: Effects of scopolamine

381. Sensory gating: new vistas

Alcohol-induced depersonalization

399. A PET study of brain activation in response to auditory hallucinations and external speech in schizophrenic patients

411. Measurement of the rate of pyruvate carboxylase in human brain by 13C MRS

415. Identification of candidate genes in schizophrenia using animal models

503. Lateralization of TPT minicolumns in patients with schizophrenia